Motive and opportunity: <i>MYC</i> rearrangements in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements (an LLMPP study)
Laura K. Hilton(BC Cancer Agency), David W. Scott(BC Cancer Agency), Waleed Alduaij(Spinal Cord Injury BC), Giorgio Inghirami(Cornell University), Pedro Farinha, Lisa M. Rimsza(Banner - University Medical Center Tucson), Wing C. Chan(Ontario Institute for Cancer Research), Kerry J. Savage(Spinal Cord Injury BC), Dennis D. Weisenburger(University of Nebraska Medical Center), Louis M. Staudt(National Cancer Institute), Laurie H. Sehn(BC Cancer Agency), Susana Ben‐Neriah(Apple (Israel)), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Joo Y. Song(City Of Hope National Medical Center), Elı́as Campo(Hospital Clínic de Barcelona), Brett Collinge(Spinal Cord Injury BC), Philipp W. Raess(Oregon Health & Science University), Klaus Beiske(Oslo University Hospital), Timothy C. Greiner(University of Nebraska Medical Center), Sarah L. Ondrejka(Cleveland Clinic), Christian Steidl(University of British Columbia), Javeed Iqbal(University of Nebraska Medical Center), Andrew J. Mungall(Spinal Cord Injury BC), Graham W. Slack(BC Cancer Agency), Tomoko Miyata‐Takata(Spinal Cord Injury BC), Haya Shaalan(Simon Fraser University), James R. Cook(Cleveland Clinic), Andrew P. Weng(Terry Fox Research Institute), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Catalina Amador(University of Miami), Ryan D. Morin(Simon Fraser University), Jan Delabie, Merrill Boyle, Elaine S. Jaffe(National Cancer Institute), Andrew L. Feldman(Mayo Clinic in Arizona), Barbara Meissner, George Wright(National Institutes of Health), Manuela Martins Cruz(Simon Fraser University), Stafania Pittaluga(National Institutes of Health), Kai Fu(Soochow University)
Cited by 35
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k